Skip to content
1 min left
0% read
SOPHiA GENETICS logo

SOPHiA GENETICS

Analytics Provider
Boston, Massachusetts, USA
Founded 2011
450

SOPHiA GENETICS is a healthcare technology democratizing data-driven medicine.

Share:

SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities.

The SOPHiA DDM™ Platform and related solutions, products, and services are currently used by more than 780 hospital, laboratory, and biopharma institutions globally.

Frequently Asked Questions About SOPHiA GENETICS

SOPHiA GENETICS is an analytics company. SOPHiA GENETICS is a healthcare technology democratizing data-driven medicine.

SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating

SOPHiA GENETICS has been operating since 2011. You can verify their legitimacy through their official website and social media presence.

SOPHiA GENETICS operates in the analytics sector of the cryptocurrency industry. Compare SOPHiA GENETICS with other analytics companies on Crypto News Navigator to evaluate services, features, and reputation before making your decision.

Before using SOPHiA GENETICS, research their track record (operating since 2011), verify their regulatory compliance, read user reviews, and understand their fee structure. Never share your private keys with any service, and start with small amounts until you are comfortable with the platform.

Safety depends on multiple factors including regulatory compliance, security practices, and track record. SOPHiA GENETICS is based in Boston, Massachusetts, USA, has been operating since 2011. Always enable two-factor authentication, use strong passwords, and never store large amounts on any third-party platform.

SOPHiA GENETICS is located in Boston, Massachusetts, USA, in the North America region. They serve customers in Global.

SOPHiA GENETICS was founded in 2011. The company currently has 450 employees.

SOPHiA GENETICS Details

SOPHiA GENETICS Offices (9)

SOPHiA GENETICS Benefits

Financial + Retirement
Child Care + Parental Leave
Office Perks
Professional Development
Health Insurance + Wellness
Culture
Vacation + Time Off
Diversity

SOPHiA GENETICS Hiring

SOPHiA GENETICS Tags

More About SOPHiA GENETICS

Work Model Details
Employees engage in a combination of remote and on-site work.
Video
Watch Video

Latest from Academy

Seven Years of IOTA Data Reveal What Actually Drives Value

Seven Years of IOTA Data Reveal What Actually Drives Value

IOTA (MIOTA) is a distributed-ledger network now built on the Move-based Rebased architecture, targeting global trade and real-world asset infrastructure. MIOTA traded near $0.058 with a market cap around $258 million, roughly 98% below its December 2017 all-time high of $5.69. Seven years of price data suggest exchange access and custody have driven IOTA value far more consistently than partnership announcements, architecture upgrades, or developer activity. The May 2025 Coordinator removal through the Rebased upgrade brought decentralized consensus and staking near 11.54% APY, yet the price boost faded within weeks. Enterprise deployments like TWIN and ADAPT continue expanding while the market waits for measurable on-chain demand to register.

Mia Halland logoMia HallandMay 23, 2026
10m
Theta Explorer Shows the Real Network Activity Behind the Hype

Theta Explorer Shows the Real Network Activity Behind the Hype

Theta (THETA) gives every holder a free, real-time research tool that most never open: its public block explorer. While the market fixates on partnership announcements and price, the explorer quietly logs what actually happens on-chain - validator uptime, transaction throughput, staking concentration, and block production. This guide walks through how to read it: spotting validators that go dark for weeks, watching whether on-chain transaction volume diverges from theta coin price, and checking how concentrated stake really is across enterprise validators like Google, Samsung, Sony, and Binance. With a hard-capped supply of one billion THETA and a market cap depressed near $204.96M, the gap between on-chain usage and exchange-side price is exactly where the explorer earns its keep. The data is public and free. The skill is knowing what you are looking at.

9m
ZBCN Price Prediction Built on Chain Data Not Hype

ZBCN Price Prediction Built on Chain Data Not Hype

Zebec Network (ZBCN) makes for a tricky price prediction. It trades around $0.00299 with a $299 million market cap, down more than 50% from its $0.007 all-time high even after a 217% yearly gain. The honest approach starts with the spreadsheet, not the headlines: the token's value comes down to three provable inputs, treasury buyback potential, payment processing volume, and user adoption. Zebec processes a self-reported $400 to $500 million in annual payroll across 250-plus enterprise customers, runs a card program that has issued 65,000-plus cards, and has plugged into traditional rails through the Nacha alliance, NatPay, FedNow, Stellar, and Circle. Yet daily protocol fees are tiny against that throughput, buyback support sits below 0.3% of market cap, and the market values each monthly active user at only a few dollars. With the final unlock complete and a deflationary model now live, ZBCN's upside hinges on how much of that payment funnel converts to verifiable on-chain volume.

8m